Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon
Background. Prevalence and incidence of drug eruptions vary around the world and are influenced by some key factors including HIV infection. Objective. This study aimed to find the peculiarities of drug eruptions in people living with HIV (PLHIV) and on antiretroviral therapy (ART). Methods. This wa...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2017/6216193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554954942840832 |
|---|---|
| author | Emmanuel Armand Kouotou Jobert Richie Nansseu Vanessa Nancy Ngono Sandra A. Tatah Anne Cecile Zoung-Kanyi Bissek Elie Claude Ndjitoyap Ndam |
| author_facet | Emmanuel Armand Kouotou Jobert Richie Nansseu Vanessa Nancy Ngono Sandra A. Tatah Anne Cecile Zoung-Kanyi Bissek Elie Claude Ndjitoyap Ndam |
| author_sort | Emmanuel Armand Kouotou |
| collection | DOAJ |
| description | Background. Prevalence and incidence of drug eruptions vary around the world and are influenced by some key factors including HIV infection. Objective. This study aimed to find the peculiarities of drug eruptions in people living with HIV (PLHIV) and on antiretroviral therapy (ART). Methods. This was a retrospective cross-sectional study including ART-taking PLHIV, aged 15+ years, followed up between January 2010 and December 2014 at the day-care unit of the Yaoundé Central Hospital, and who presented with drug eruptions after ART initiation. Results. Of 6,829 ART-experiencing PLHIV, 41 presented with drug eruptions, giving a prevalence of 0.6%. The M/F sex ratio equaled 0.17. The mean age was 41.07 ± 11.36 years. Benign drug eruptions accounted for 83.3%. Milder forms were essentially maculopapular exanthema (36.6%), fixed pigmented erythema (7.3%), and urticaria (4.9%). Severe forms were represented by multiform erythema (4.9%), toxic epidermal necrolysis (2.4%), and drug hypersensitivity syndrome (2.4%). The Zidovudine + Lamivudine + Efavirenz ART-protocol was received by 48.8% of patients and 69% of patients were receiving Cotrimoxazole prophylaxis. Nevirapine, Efavirenz, Zidovudine, and Cotrimoxazole were suspected as the potential causes in 43.7%, 4.8%, 2.4%, and 26.8% of cases, respectively. Conclusion. Drug eruptions seem infrequent among ART-exposed HIV infected adult Cameroonians. |
| format | Article |
| id | doaj-art-20e2a923a3aa40f5a19149b2152c4ed5 |
| institution | Kabale University |
| issn | 1687-6105 1687-6113 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Dermatology Research and Practice |
| spelling | doaj-art-20e2a923a3aa40f5a19149b2152c4ed52025-02-03T05:49:56ZengWileyDermatology Research and Practice1687-61051687-61132017-01-01201710.1155/2017/62161936216193Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, CameroonEmmanuel Armand Kouotou0Jobert Richie Nansseu1Vanessa Nancy Ngono2Sandra A. Tatah3Anne Cecile Zoung-Kanyi Bissek4Elie Claude Ndjitoyap Ndam5Biyem-Assi District Hospital, Yaoundé, CameroonFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonYaoundé University Teaching Hospital, Yaoundé, CameroonYaoundé University Teaching Hospital, Yaoundé, CameroonFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonFaculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, CameroonBackground. Prevalence and incidence of drug eruptions vary around the world and are influenced by some key factors including HIV infection. Objective. This study aimed to find the peculiarities of drug eruptions in people living with HIV (PLHIV) and on antiretroviral therapy (ART). Methods. This was a retrospective cross-sectional study including ART-taking PLHIV, aged 15+ years, followed up between January 2010 and December 2014 at the day-care unit of the Yaoundé Central Hospital, and who presented with drug eruptions after ART initiation. Results. Of 6,829 ART-experiencing PLHIV, 41 presented with drug eruptions, giving a prevalence of 0.6%. The M/F sex ratio equaled 0.17. The mean age was 41.07 ± 11.36 years. Benign drug eruptions accounted for 83.3%. Milder forms were essentially maculopapular exanthema (36.6%), fixed pigmented erythema (7.3%), and urticaria (4.9%). Severe forms were represented by multiform erythema (4.9%), toxic epidermal necrolysis (2.4%), and drug hypersensitivity syndrome (2.4%). The Zidovudine + Lamivudine + Efavirenz ART-protocol was received by 48.8% of patients and 69% of patients were receiving Cotrimoxazole prophylaxis. Nevirapine, Efavirenz, Zidovudine, and Cotrimoxazole were suspected as the potential causes in 43.7%, 4.8%, 2.4%, and 26.8% of cases, respectively. Conclusion. Drug eruptions seem infrequent among ART-exposed HIV infected adult Cameroonians.http://dx.doi.org/10.1155/2017/6216193 |
| spellingShingle | Emmanuel Armand Kouotou Jobert Richie Nansseu Vanessa Nancy Ngono Sandra A. Tatah Anne Cecile Zoung-Kanyi Bissek Elie Claude Ndjitoyap Ndam Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon Dermatology Research and Practice |
| title | Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
| title_full | Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
| title_fullStr | Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
| title_full_unstemmed | Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
| title_short | Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
| title_sort | prevalence and clinical profile of drug eruptions among antiretroviral therapy exposed hiv infected people in yaounde cameroon |
| url | http://dx.doi.org/10.1155/2017/6216193 |
| work_keys_str_mv | AT emmanuelarmandkouotou prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon AT jobertrichienansseu prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon AT vanessanancyngono prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon AT sandraatatah prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon AT annececilezoungkanyibissek prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon AT elieclaudendjitoyapndam prevalenceandclinicalprofileofdrugeruptionsamongantiretroviraltherapyexposedhivinfectedpeopleinyaoundecameroon |